CVE-2022-26389

highpriority · track · 0EPSS 0.003 · 20 %ileEUUS
grimoire priorityP2 · Scheduled
Exploitable?
—
no known exploitation
Likely / severe?
0.29% (20th) EPSS
CVSS 7.7 · high
Is it mine?
12 products
Check your exposure
Who says so?
3 sources
cnnvd · enisa_euvd · cisa_csaf_ot

EPSS · scored 2026-10-23

An improper access control vulnerability may allow privilege escalation.This issue affects:  * ELI 380 Resting Electrocardiograph: Versions 2.6.0 and prior;  * ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph: Versions 2.3.1 and prior;  * ELI 250c/BUR 250c Resting Electrocardiograph: Versions 2.1.2 and prior;  * ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiograph: Versions 2.2.0 and prior.

01

remediations

Vendor fix, mitigation, or workaround guidance, as published by each source.

A vendor fix is available.

  • FixedWelch Allyn ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiographcisa_csaf_ot

    Hillrom has released software updates for all impacted devices to address these vulnerabilities. New product versions that mitigate these vulnerabilities are available as follows:

  • FixedWelch Allyn ELI 250c/BUR 250c Resting Electrocardiographcisa_csaf_ot

    Hillrom has released software updates for all impacted devices to address these vulnerabilities. New product versions that mitigate these vulnerabilities are available as follows:

  • FixedWelch Allyn ELI 280/BUR280/MLBUR 280 Resting Electrocardiographcisa_csaf_ot

    Hillrom has released software updates for all impacted devices to address these vulnerabilities. New product versions that mitigate these vulnerabilities are available as follows:

  • FixedWelch Allyn ELI 380 Resting Electrocardiographcisa_csaf_ot

    Hillrom has released software updates for all impacted devices to address these vulnerabilities. New product versions that mitigate these vulnerabilities are available as follows:

02

cvss

Technical severity, 0–10. One row per scoring source.

7.7
010

base score 0–10 · higher = more severe · hover a vector to decode

v3.07.7highCVSS:3.0/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:L/A:Hsecondary · CISA US
v3.17.7highCVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:L/A:Hsecondary · ENISA EU
v3.17.7highCVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:L/A:Hsecondary · productsecurity@baxter.comexploitability 1.8 · impact 5.3
v3.17.1highCVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:L/A:H/E:Usecondary · CVSS-BT (t0sche)
03

ssvc

A stakeholder decision — act, attend, or track — from exploitation and impact.

Trackcoordinatorcisa_ssvcUS
04

weaknesses

The CWE weakness classes this flaw belongs to.

05

affected products (12)

Products and version ranges known to be affected.

06

advisories (1)

Vendor and ecosystem advisories describing this.

  • ICSMA-22-167-01Hillrom Medical Device Management2022-06-16icsa · cisa_csaf_otUS

    Successful exploitation of these vulnerabilities could allow an attacker to compromise software security by executing commands, gaining privileges, reading sensitive information, evading detection, etc.

07

also known as (3)

Other names and identifiers for this entity.

08

sources

Which sources assert this record, and when.

published 2025-02-07modified 2026-06-17
09

references (9)

External citations — patches, advisories, analysis.

scry

Attackers weaponise vulnerabilities like this against internet-exposed services. See what is exposed on your perimeter with a free passive scan.

Free scan